Who owns CHEMOMAB THERAPEUTICS LTD?
- Ticker: CMMB
- CUSIP Number: 16385c104
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 1.7M | $3.2M | 0% | Dec 2024 |
|
| Sphera Funds Management | 1.2M | $2.2M | 0% | Dec 2024 |
|
| Yelin Lapidot Holdings Management | 744k | $1.3M | -8% | Dec 2024 |
|
| Ikarian Capital | 213k | $386k | 0% | Dec 2024 |
|
| Morgan Stanley | 104k | $189k | -74% | Dec 2024 |
|
| Kestra Private Wealth Services | 31k | $57k | 0% | Dec 2024 |
|
| Boothbay Fund Management | 26k | $47k | -1% | Dec 2024 |
|
| XTX Topco | 25k | $45k | 64% | Dec 2024 |
|
| Rhumbline Advisers | 24k | $26k | 0% | Mar 2025 |
|
| Virtu Financial | 14k | $26k | 100% | Dec 2024 |
|
| GAMMA Investing | 11k | $12k | 116% | Mar 2025 |
|
| Wetzel Investment Advisors | 10k | $18k | 100% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 6.5k | $12k | 100% | Dec 2024 |
|
| Moser Wealth Advisors | 500.00 | $905.000000 | 0% | Dec 2024 |
|
| UBS Group | 485.00 | $970.000000 | -79% | Dec 2024 |
|
| SBI Securities | 100.00 | $181.000000 | 100% | Dec 2024 |
|
Who sold out of Chemomab Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Two Sigma Securities | Sep 2024 | 40k | $63k |
| Hrt Financial | Sep 2024 | 14k | $21k |
| Millennium Management | Sep 2024 | 11k | $17k |
| Jpmorgan Chase & Co | Sep 2024 | 1.1k | $1.7k |